dc.contributor.author
Lurje, Isabella
dc.contributor.author
Czigany, Zoltan
dc.contributor.author
Eischet, Sarah
dc.contributor.author
Bednarsch, Jan
dc.contributor.author
Ulmer, Tom Florian
dc.contributor.author
Isfort, Peter
dc.contributor.author
Strnad, Pavel
dc.contributor.author
Trautwein, Christian
dc.contributor.author
Tacke, Frank
dc.contributor.author
Neumann, Ulf Peter
dc.contributor.author
Lurje, Georg
dc.date.accessioned
2024-12-19T13:41:27Z
dc.date.available
2024-12-19T13:41:27Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/46035
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-45745
dc.description.abstract
Cholangiocarcinoma (CCA) is a rare but highly aggressive malignancy of the biliary system. Although it is amenable to surgical resection in early disease, outcomes are frequently dismal. Here, we investigated the prevalence of body composition (BC) alterations and their prognostic role for surgical patients with intrahepatic (iCCA) and perihilar (pCCA) disease. Patients undergoing curative-intent surgery for iCCA or pCCA between 2010 and 2019 at University Hospital Aachen were included. Axial computed tomography images were retrospectively assessed with a segmentation tool (3D Slicer) at the level of the third lumbar vertebra to determine lumbar skeletal muscle (SM) index, mean SM radiation attenuation, and visceral fat area. The related BC pathologies sarcopenia, myosteatosis, visceral obesity, and sarcopenic obesity were determined using previously described cutoffs. A total of 189 patients (86 with iCCA, 103 with pCCA) were included. Alterations of BC were highly prevalent in iCCA and pCCA, respectively: sarcopenia, 33% (28/86) and 39% (40/103); myosteatosis, 66% (57/86) and 66% (68/103); visceral obesity, 56% (48/86) and 67% (69/103); sarcopenic obesity, 11% (9/86) and 17% (17/103). Sarcopenia and myosteatosis did not have a significant prognostic role for disease-free survival (DFS) and overall survival (OS). Patients with iCCA with sarcopenic obesity (n = 9) had significantly shorter OS than patients without sarcopenic obesity (n = 7; log-rank p = 0.002; median OS, 11 months and 31 months; 1-year mortality, 55.6% [5/9] and 22% [17/77]; 5-year mortality, 88.9% [8/9] and 61% [47/77], respectively). In multivariable analysis, only tumor-related risk factors remained prognostic for DFS and OS. Sarcopenic obesity may affect clinical outcomes after curative-intent surgery for iCCA, indicating that imaging-based analysis of BC may hold prognostic value for long-term survival and could aid preoperative patient selection.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
Cholangiocarcinoma
en
dc.subject
Body composition alterations
en
dc.subject
Sarcopenic obesity
en
dc.subject
Prognostic value
en
dc.subject
Curative-intent surgery
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1002/hep4.2004
dcterms.bibliographicCitation.journaltitle
Hepatology Communications
dcterms.bibliographicCitation.number
9
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
2400
dcterms.bibliographicCitation.pageend
2417
dcterms.bibliographicCitation.volume
6
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35616275
dcterms.isPartOf.eissn
2471-254X